Role of neurotrophic factors in depression

Cited by (667)

Items 101–200 of 667

1. Unfolding the Role of BDNF as a Biomarker for Treatment of Depression
   Tarapati Rana, Tapan Behl, Aayush Sehgal, Pranay Srivastava, SIMONA GABRIELA BUNGAU · 2020 · Journal of Molecular Neuroscience
2. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice
   Païzanis, Eleni, Renoir, Thibault, Lelievre, Vincent, Saurini, Françoise, Melfort, Maxette, Gabriel, Cecilia, Barden, Nicholas, Mocaër, Elisabeth, Hamon, Michel, Lanfumey, Laurence · 2010 · The International Journal of Neuropsychopharmacology
3. Fibroblast Growth Factor Receptor 1– 5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity
   Dasiel O. Borroto‐Escuela, Wilber Romero‐Fernandez, Giuseppa Mudò, Mileidys Pérez‐Alea, Francisco Ciruela, Alexander O. Tarakanov, Manuel Narváez, Valentina Di Liberto, Luigi F. Agnati, Natale Belluardo et al. · 2011 · Biological Psychiatry
4. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
   Anne Dekeyne, Clotilde Mannoury la Cour, Alain Gobert, Mauricette Brocco, Franćoise Lejeune, Florence Serres, Trevor Sharp, Annie Daszuta, Amélie Soumier, Mariusz Papp et al. · 2008 · Psychopharmacology
5. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: Evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects
   E. Sylvester Vizi, Máté Kisfali, Tibor Lőrincz · 2012 · Brain Research Bulletin
6. Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression: Implications for Pharmacological Treatment
   Castrén, Eero, Rantamäki, Tomi · 2010 · CNS Drugs
7. Chronically Restricted or Disrupted Sleep as a Causal Factor in the Development of Depression
   Peter Meerlo, Robbert Havekes, Axel Steiger · 2015 · Current topics in behavioral neurosciences
8. Chronic Administration of Ketamine Elicits Antidepressant‐Like Effects in Rats without Affecting Hippocampal Brain‐Derived Neurotrophic Factor Protein Levels
   Lêda Soares Brandão Garcia, Clarissa Martinelli Comim, Samira Silva Valvassori, Gislaine Z. Réus, Ana C. Andreazza, Laura Stertz, Gabriel R. Fries, Elaine Cristina Gavioli, Flávio Pereira Kapczinski, João Quevedo · 2008 · Basic & Clinical Pharmacology & Toxicology
9. Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia
   Koga, Minori, Ishiguro, Hiroki, Yazaki, Saori, Horiuchi, Yasue, Arai, Makoto, Niizato, Kazuhiro, Iritani, Shuji, Itokawa, Masanari, Inada, Toshiya, Iwata, Nakao et al. · 2009 · Human Molecular Genetics
10. Chronic stress-induced cellular changes in the medial prefrontal cortex and their potential clinical implications: Does hemisphere location matter?
    Boldizsár Czéh, Claudia Perez‐Cruz, Eberhard Fuchs, Gabriele Flügge · 2008 · Behavioural Brain Research
11. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression
    Haenisch, Britta, Bilkei‐Gorzo, Andras, Caron, Marc G., Bönisch, Heinz · 2009 · Journal of Neurochemistry
12. Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
    Lindholm, Jesse S. O., Castrén, Eero · 2014 · Frontiers in Behavioral Neuroscience
13. The effects of ginsenoside Rg1 on chronic stress induced depression-like behaviors, BDNF expression and the phosphorylation of PKA and CREB in rats
    Zonglian Liu, Yanhua Qi, Zhiqiang Cheng, Xingyue Zhu, C. Fan, Shu Yan Yu · 2016 · Neuroscience
14. Oxidative Damage of Tryptophan Hydroxylase-2 Mediated by Peroxisomal Superoxide Anion Radical in Brains of Mouse with Depression
    Qi Ding, Ying Tian, Xin Wang, Ping Li, Di Su, Chuanchen Wu, Wen Zhang, Bo Tang · 2020 · Journal of the American Chemical Society
15. Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: How important is BDNF ?
    Anthony Markham, Rasneer Sonia Bains, P Franklin, Michael Spedding · 2013 · British Journal of Pharmacology
16. Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety
    Gundersen, Brigitta B., Blendy, Julie A. · 2009 · Neuropharmacology
17. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
    Gislaine Z. Réus, Roberto B. Stringari, Tamires R. Kirsch, Gabriel R. Fries, Flávio Pereira Kapczinski, Rafael Roesler, João Quevedo · 2009 · Brain Research Bulletin
18. Long‐lasting neurotoxic effects of exposure to methylmercury during development
    Sandra Ceccatelli, R. Bose, Karin Edoff, Natalia R. Onishchenko, Stefan D. Spulber · 2013 · Journal of Internal Medicine
19. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
    Lisa Cardamone, MJ Salzberg, Terence John O'Brien, Nigel C. Jones · 2012 · British Journal of Pharmacology
20. Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats
    Lin Zhang, Junxia Luo, Minghua Zhang, Wei Yao, Xuelian Ma, Shu Yan Yu · 2014 · The International Journal of Neuropsychopharmacology
21. Reduced platelet BDNF level in patients with major depression
    Lee, Bun-Hee, Kim, Yong-Ku · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
22. Sex differences in the outcome of juvenile social isolation on HPA axis function in rats
    Maria Giuseppina Pisu, A. Garau, Giorgia Boero, Francesca Biggio, Valeria Pibiri, Riccardo Dore, Valentina Locci, Elena Paci, Patrizia Porcu, Mariangela Serra · 2016 · Neuroscience
23. Neuropathological relationship between major depression and dementia: A hypothetical model and review
    Helena Kyunghee Kim, Paula Villela Nunes, Kátia Cristina de Oliveira, Lionel Trevor Young, Beny Lafer · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
24. NCAM in Neuropsychiatric and Neurodegenerative Disorders
    Leann H. Brennaman, Patricia F. Maness · 2009 · Advances in experimental medicine and biology
25. Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress
    Yadira Ibargüen-Vargas, Alexandre Surget, Patrick Vourc’h, Samuel Leman, Christian Robert Andres, Alain Michel Gardier, Catherine Belzung · 2009 · Behavioural Brain Research
26. Soluble βamyloid1‐42: a critical player in producing behavioural and biochemical changes evoking depressive‐related state?
    Marilena Colaianna, Paolo Tucci, Margherita Zotti, Maria Grazia Morgese, Stefania Schiavone, Stefano M. Govoni, V. Cuomo, Luigia Trabace · 2010 · British Journal of Pharmacology
27. Maternal Deprivation Induces Depressive-like Behaviour and Alters Neurotrophin Levels in the Rat Brain
    Gislaine Z. Réus, Roberto B. Stringari, Karine F. Ribeiro, Andreza L. Cipriano, Bruna Panizzutti, Laura Stertz, Camila Lersch, Flávio Pereira Kapczinski, João Quevedo · 2010 · Neurochemical Research
28. Early life influences on emotional reactivity: Evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels
    Cirulli, Francesca, Berry, Alessandra, Bonsignore, Luca Tommaso, Capone, Francesca, D’Andrea, Ivana, Aloe, Luigi, Branchi, Igor, Alleva, Enrico · 2010 · Neuroscience & Biobehavioral Reviews
29. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial
    Solati, Zahra, Jazayeri, Shima, Tehrani-Doost, Mehdi, Mahmoodianfard, Salma, Gohari, Mahmood Reza · 2015 · Nutritional Neuroscience
30. Neurobiology of depression: A neurodevelopmental approach
    Juan M. Lima‐Ojeda, Rainer Rupprecht, Thomas C. Baghai · 2017 · The World Journal of Biological Psychiatry
31. Animal models of depression: pros and cons
    Jaanus Harro · 2018 · Cell and Tissue Research
32. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression
    Fenghua Chen, Torsten M. Madsen, Gregers Wegener, Jens Randel Nyengaard · 2009 · Hippocampus
33. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice
    Jesse Lindholm, Henri Autio, Liisa Vesa, Hanna Antila, Lothar Lindemann, Marius Christian Hoener, Phil Skolnick, Tomi Rantamäki, Eero Ċastrén · 2011 · Neuropharmacology
34. Neuroplasticity and major depression, the role of modern antidepressant drugs
    Gianluca Serafini · 2012 · World Journal of Psychiatry
35. Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term Potentiation
    Alme, Maria Nordheim, Wibrand, Karin, Dagestad, Grethe, Bramham, Clive R. · 2007 · Neural Plasticity
36. Biomarkers of post-covid depression
    Lorkiewicz, Piotr, Waszkiewicz, Napoleon · 2021 · Journal of Clinical Medicine
37. Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field
    Kjell Fuxé, Dasiel O. Borroto‐Escuela, Wilber Romero‐Fernandez, Miklós Palkovits, Alexander O. Tarakanov, Francisco Ciruela, Luigi F. Agnati · 2013 · Neuropsychopharmacology
38. Resveratrol reverses chronic restraint stress-induced depression-like behaviour: Involvement of BDNF level, ERK phosphorylation and expression of Bcl-2 and Bax in rats
    Xueer Wang, Yunkai Xie, Tiantian Zhang, Shishi Bo, Xuemei Bai, Hansen Liu, Tong Li, Song Liu, Yaru Zhou, Cong Xiang et al. · 2016 · Brain Research Bulletin
39. Antidepressant-like effects of albiflorin extracted from Radix paeoniae Alba
    Yulu Wang, Jingxia Wang, Xiaoxu Hu, Li Chen, Zhi-Kun Qiu, Nan Zhao, Zi-Dan Yu, Shu-Zheng Sun, Yuanyuan Xu, Yan Guo et al. · 2015 · Journal of Ethnopharmacology
40. Salidroside attenuates lipopolysaccharide (LPS) induced serum cytokines and depressive-like behavior in mice
    Lingpeng Zhu, Tingting Wei, Jing Gao, Xiayun Chang, He He, Mingxing Miao, Tianhua Yan · 2015 · Neuroscience Letters
41. Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
    Giovanni Martinotti, Mauro Pettorruso, Domenico De Berardis, Paola Annunziata Varasano, Gabriella Lucidi Pressanti, Valeria De Remigis, Alessandro Valchera, Valerio Ricci, Marco Di Nicola, Luigi Janiri et al. · 2016 · The International Journal of Neuropsychopharmacology
42. Exercise as a Treatment for Schizophrenia: A Review
    Steven J. Girdler, Jamie Confino, Mary E. Woesner · 2025 · Psychopharmacology Bulletin
43. Serum BDNF Concentrations Show Strong Seasonal Variation and Correlations with the Amount of Ambient Sunlight
    Marc L. Molendijk, Judith Haffmans, Boudewijn A.A. Bus, Philip Spinhoven, Brenda W.J.H. Penninx, Jos Prickaerts, Richard C. Oude Voshaar, Bernet M. Elzinga · 2012 · PLoS ONE
44. Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness
    Vanja Đurić, Sarah Clayton, Mai Lan Leong, Li‐Lian Yuan · 2016 · Neural Plasticity
45. Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain–gut axis
    Kohei Takahashi, Osamu Nakagawasai, Wataru Nemoto, Takayo Odaira, Wakana Sakuma, Hiroshi Onogi, Hiroaki Nishijima, Ryuji Furihata, Yukio Nemoto, Hiroyuki Iwasa et al. · 2019 · Journal of Neuroinflammation
46. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
    Fortunato, Jucélia J., Réus, Gislaine Z., Kirsch, Tamires R., Stringari, Roberto B., Fries, Gabriel R., Kapczinski, Flávio, Hallak, Jaime E., Zuardi, Antônio W., Crippa, José A., Quevedo, João · 2010 · Journal of Neural Transmission
47. The prefrontal–limbic network in depression: Modulation by hypothalamus, basal ganglia and midbrain
    Maxwell R. Bennett · 2011 · Progress in Neurobiology
48. Tuning and Fine-Tuning of Synapses with Adenosine
    Ana Maria Sebastião, Joaquim Alexandre Ribeiro · 2009 · Current Neuropharmacology
49. NGF, Brain and Behavioral Plasticity
    Alessandra Berry, Erika Bindocci, Enrico Alleva · 2012 · Neural Plasticity
50. Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression
    Ota, Kristie T., Duman, Ronald S. · 2013 · Neurobiology of Disease
51. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression
    Yukio Ago, Shinsuke Arikawa, Miyuki Yata, Koji Yano, Michikazu Abe, Kazuhiro Takuma, Toshio Matsuda · 2008 · Neuropharmacology
52. Etiological mechanisms of post-stroke depression: a review
    Jing‐Yuan Fang, Qi Hui Cheng · 2009 · Neurological Research
53. Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice
    Lin Zhang, Tianyuan Xu, Shuang Wang, Lanqing Yu, Dexiang Liu, Ren‐Zhi Zhan, Shu Yan Yu · 2012 · Behavioural Brain Research
54. Neuroplasticity and the next wave of antidepressant strategies
    Hayley, Shawn, Litteljohn, Darcy · 2013 · Frontiers in Cellular Neuroscience
55. The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside
    Shweta Sharma, Shivani Chawla, Praveen Kumar, Rizwan Ahmad, Prabhakar Kumar Verma · 2024 · Brain Research
56. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways
    Iandra Holzmann, Luísa Mota da Silva, José Afonso Corrêa da Silva, Viviane Miranda Bispo Steimbach, Márcia María de Souza · 2015 · Pharmacology Biochemistry and Behavior
57. Man and the Microbiome: A New Theory of Everything?
    Mary Butler, John F. Cryan, Timothy G. Dinan · 2019 · Annual Review of Clinical Psychology
58. Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats
    Amine Bahí, Vijay Chandrasekar, Jean‐Luc Dreyer · 2014 · Psychoneuroendocrinology
59. Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
    Marc Udina, Ricard Navinés, Elfi Egmond, Giovanni Oriolo, Klaus Langohr, Dolors Giménez, M Valdés, Esther Gómez‐Gil, Iría Grande, Mónica Gratacòs et al. · 2015 · The International Journal of Neuropsychopharmacology
60. Direct Inhibitory Effect of Fluoxetine on N-Methyl-D-Aspartate Receptors in the Central Nervous System
    Bernadett K. Szász, Árpád Mike, Róbert Károly, Zoltán Gerevich, Péter Illés, E. Sylvester Vizi, J. Kiss · 2007 · Biological Psychiatry
61. TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice
    Marie Lou Camara, Frances Corrigan, Emily Joy Jaehne, Magdalene C. Jawahar, Helen Anscomb, Heinrich Körner, Bernhard Theodor Baune · 2013 · Psychoneuroendocrinology
62. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke
    Lingli Yang, Zhijun Zhang, Dingming Sun, Zhi Xu, Yonggui Yuan, Xiangrong Zhang, Lingjiang Li · 2010 · International Journal of Geriatric Psychiatry
63. Neuropeptides in depression: Role of VGF
    Smita Thakker‐Varia, Janet Alder · 2008 · Behavioural Brain Research
64. Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice
    Qing‐Qiu Mao, Zhen Huang, Xiaoming Zhong, Yan‐Fang Xian, Siu‐Po Ip · 2013 · Behavioural Brain Research
65. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: The HPA axis, BDNF expression and phosphorylation of ERK
    Zhen Wang, Jianhua Gu, Xueer Wang, Kai Xie, Qinsong Luan, Nianqing Wan, Qun Zhang, Hong Jiang, Dexiang Liu · 2013 · Pharmacology Biochemistry and Behavior
66. Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression
    Tamás Kozicz, Debbie T. W. M. Ouwens, Gábor Faludi, Miklós Palkovits, Eric W. Roubos · 2008 · Neuroscience
67. Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain
    Qing‐Qiu Mao, Yan‐Fang Xian, Siu‐Po Ip, Sam-Hip Tsai, Chun‐Tao Che · 2010 · Behavioural Brain Research
68. Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway
    Nitin Bhanudas Gawali, Vipin D. Bulani, Malvika Gursahani, Padmini S. Deshpande, Pankaj S. Kothavade, Archana Ramesh Juvekar · 2017 · Brain Research
69. Imipramine Treatment Improves Cognitive Outcome Associated with Enhanced Hippocampal Neurogenesis after Traumatic Brain Injury in Mice
    Xiaodi Han, Jing Tong, Jun Zhang, Arash Farahvar, Ernest Wang, Jiankai Yang, Uzma Samadani, Douglas H. Smith, Jason Haitao Huang · 2011 · Journal of Neurotrauma
70. Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects
    Fenghua Chen, Aksel Bertelsen, Ida E. Holm, Jens Randel Nyengaard, Raben Rosenberg, Karl‐Anton Dorph‐Petersen · 2019 · Brain Research
71. Synaptic plasticity model of therapeutic sleep deprivation in major depression
    Elias Wolf, Marion Kühn, Claus Normann, F Mainberger, Jonathan Gabriel Maier, Sarah Maywald, Aliza Bredl, Stefan Klöppel, Knut P. H. Biber, Dietrich van Calker et al. · 2015 · Sleep Medicine Reviews
72. Functional interactions between steroid hormones and neurotrophin BDNF
    Tadahiro Numakawa · 2010 · World Journal of Biological Chemistry
73. Future antidepressant targets: neurotrophic factors and related signaling cascades
    Heath D. Schmidt, Mounira Banasr, Ronald S. Duman · 2008 · Drug Discovery Today Therapeutic Strategies
74. Retinoid-Mediated Regulation of Mood: Possible Cellular Mechanisms
    Kally C. O’Reilly, Sarah Bailey, Michelle A. Lane · 2008 · Experimental Biology and Medicine
75. The Effects of Calorie Restriction in Depression and Potential Mechanisms
    Yifan Zhang, Changhong Liu, Yinghao Zhao, Xingyi Zhang, Bingjin Li, Ranji Cui · 2015 · Current Neuropharmacology
76. Epigenetics in mood disorders
    Patrick O. McGowan, Tadafumi Kato · 2007 · Environmental Health and Preventive Medicine
77. Role of BDNF in Central Motor Structures and Motor Diseases
    Yanyan He, Xiaoyang Zhang, Wing‐Ho Yung, Jing‐Ning Zhu, Jianjun Wang · 2013 · Molecular Neurobiology
78. The role of microRNAs in synaptic plasticity, major affective disorders and suicidal behavior
    Gianluca Serafini, Maurizio Pompili, Marco Innamorati, Gloria Giordano, Franco Montebovi, Leo Sher, Yogesh Dwivedi, Paolo Girardi · 2012 · Neuroscience Research
79. Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes
    Vanja Đurić, Ronald S. Duman · 2012 · Cellular and Molecular Life Sciences
80. Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives
    Mehran Shayganfard · 2021 · Biological Trace Element Research
81. Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
    Maurizio Pompili, Gianluca Serafini, Marco Innamorati, Paola Venturini, Paolo Fusar‐Poli, Leo Sher, Mario Amore, Paolo Girardi · 2013 · The World Journal of Biological Psychiatry
82. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.
    Krystal, John H., Tolin, David F., Sanacora, Gerard, Castner, Stacy A., Williams, Graham V., Aikins, Deane E., Hoffman, Ralph E., D'Souza, D. Cyril · 2009 · Drug Discovery Today
83. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression
    Michele L. Pucak, Katherine A. L. Carroll, Douglas A. Kerr, Adam L. Kaplin · 2007 · Dialogues in Clinical Neuroscience
84. Environmental Enrichment Induces Behavioral Recovery and Enhanced Hippocampal Cell Proliferation in an Antidepressant-Resistant Animal Model for PTSD
    Hendrikus Hendriksen, Jolanda Prins, Berend Olivier, Ronald S. Oosting · 2010 · PLoS ONE
85. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants
    Marianne Hald Larsen, Anders Hay‐Schmidt, Lars Christian B. Rønn, Jens Damsgaard Mikkelsen · 2007 · European Journal of Pharmacology
86. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: Role of BDNF signalling
    Olivia F. O’Leary, Xuefei Wu, Eero Ċastrén · 2008 · Psychoneuroendocrinology
87. Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro
    Theodore A. Slotkin, Frederic J. Seidler, Fabio Fumagalli · 2008 · Brain Research Bulletin
88. Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca2+‐permeable TRPC6 channels
    Kristina Leuner, Wei Li, Michelle D. Amaral, Stephanie Rudolph, Gastón Diego Calfa, Anita M. Schuwald, Christian Harteneck, Takafumi Inoue, Lucas D. Pozzo‐Miller · 2012 · Hippocampus
89. The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment
    Annamaria Cattaneo, Antonella Sesta, Francesca Calabrese, Gabriela Nielsen, Marco Andrea Riva, Massimo Gennarelli · 2010 · Neuropsychopharmacology
90. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments
    Andrew F. Leuchter, Aimee M. Hunter, David E. Krantz, Ian A. Cook · 2015 · Annals of the New York Academy of Sciences
91. Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action?
    Hoda Eliwa, Catherine Belzung, Alexandre Surget · 2017 · Biochemical Pharmacology
92. Imipramine Induces Brain-Derived Neurotrophic Factor mRNA Expression in Cultured Astrocytes
    Takano, Katsura, Yamasaki, Hiroshi, Kawabe, Kenji, Moriyama, Mitsuaki, Nakamura, Yoichi · 2012 · Journal of Pharmacological Sciences
93. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only
    Mohammad Haghighi, Iraj Salehi, Parichehr Erfani, Leila Jahangard, Hafez Bajoghli, Edith Holsboer‐Trachsler, Serge Brand · 2013 · Journal of Psychiatric Research
94. The total flavonoids extracted from Xiaobuxin-Tang up-regulate the decreased hippocampal neurogenesis and neurotrophic molecules expression in chronically stressed rats
    Lei An, You‐Zhi Zhang, Neng-Jiang Yu, Xinmin Liu, Nan Zhao, Li Yuan, Hongxia Chen, Yunfeng Li · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
95. Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress
    Girstautė Dagytė, Ilaria Crescente, Folkert Postema, Laure Seguin, C. Gabriel, Elisabeth Mocaër, Johan A. den Boer, Jaap M. Koolhaas · 2010 · Behavioural Brain Research
96. Depression and Cardiovascular Disease: The Viewpoint of Platelets
    Patrizia Amadio, Marta Zarà, Leonardo Sandrini, Alessandro Ieraci, Silvia Stella Barbieri · 2020 · International Journal of Molecular Sciences
97. Long-Term Duloxetine Treatment Normalizes Altered Brain-Derived Neurotrophic Factor Expression in Serotonin Transporter Knockout Rats through the Modulation of Specific Neurotrophin Isoforms
    Francesca Calabrese, Raffaella Molteni, Annamaria Cattaneo, Flavia Macchi, Giorgio Racagni, Massimo Gennarelli, Bart A. Ellenbroek, Marco Andrea Riva · 2010 · Molecular Pharmacology
98. Circuits Regulating Pleasure and Happiness—Mechanisms of Depression
    ANTON J. M. LOONEN, Svetlana А. Ivanova · 2016 · Frontiers in Human Neuroscience
99. Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection
    Ana Maria Sebastião, Joaquim Alexandre Ribeiro · 2009 · British Journal of Pharmacology
100. Relationship between Chronic Pain and Cognition in Cognitively Intact Older Persons and in Patients with Alzheimer’s Disease
     Erik Scherder, Laura H. P. Eggermont, Bart Plooij, Jeroen Oudshoorn, Pieter J. Vuijk, Gisele P Pickering, Stefan Lautenbacher, Wilco P. Achterberg, Joukje M. Oosterman · 2008 · Gerontology